ASXL1 but not TET2 mutations adversely impact overall survival of patients suffering systemic mastocytosis with associated clonal hematologic non-mast-cell diseases.
published in: PLOS One
date of publication: 2014-01-21
language: English
main subject: mast cell, systemic mastocytosis
Cites articles 22
- 2009-05-28
Date
Title
Article - wd:Q37499442